News | August 26, 2025
Remedium Lifecare charts 4X growth strategy
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Phase 1 dosing is expected to finish by the end of 2025
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Subscribe To Our Newsletter & Stay Updated
